TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
EDIT

Editas Medicine Inc

Healthcare · Biotechnology

2.80$ +2.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement EDIT
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.00 0.05 0.19 0.34 0.68 0.41 1.55 0.38 0.29 1.03 0.39 0.46
0.05 1.98 0.53 1.77 2.06 1.92 1.94 2.70 0.07 0.09 0.08 2.42 0.06
-0.05 -1.98 -0.48 -1.58 -1.72 -1.25 -1.53 1.55 0.38 0.29 0.95 -2.03 0.46
0.05 1.98 0.53 1.77 2.06 1.92 1.94 2.70 2.11 2.55 2.34 2.42 1.01
0.12 2.98 0.51 1.44 1.25 1.17 1.29 1.15 1.13 1.03 0.92 0.87 0.56
0.12 4.96 1.03 3.20 3.31 3.09 1.29 3.85 3.23 3.58 3.18 1.02 1.58
-0.17 -4.96 -0.99 -3.02 -2.97 -2.41 -2.82 -2.30 -2.86 -3.29 -2.23 -3.05 -1.12
– 0.01 0.00 0.00 0.02 0.07 0.15 0.04 0.08 0.06 – 0.03 0.07
-0.18 -5.34 -2.04 -3.02 -2.98 -2.33 -2.68 -1.98 -2.85 -3.21 -2.02 -2.88 -1.80
0.00 -0.35 -1.06 -0.04 -0.03 -0.07 -0.21 -0.11 -0.11 -0.23 0.08 – –
-0.18 -5.34 -2.04 -3.02 -2.98 -2.33 -2.68 -1.87 -2.74 -2.98 -2.02 -2.88 -1.80
-0.17 -5.27 -2.02 -2.98 -2.89 -2.35 -2.76 -2.23 -2.78 -3.20 -1.94 -2.83 -1.67

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?